| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 04/18/2002 | US20020045766 Preparation of pyrethroids. |
| 04/18/2002 | US20020045753 E.g., (S)-N-(4-(4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2 -yl)-carbonyl)-1-piperazinyl)phenyl)-2-thiophenecarboximidamide , or a salt thereof. |
| 04/18/2002 | US20020045629 Sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/18/2002 | US20020045620 Readily metabolized by the metabolic drug detoxification systems; metabolized by serum or intracellular hydrolases and esterases; shorthalf-life; noninsulin-dependent diabetes mellitus (NIDDM) (Type II); side effect reduction |
| 04/18/2002 | CA2424292A1 Tricyclic compounds and uses thereof |
| 04/17/2002 | EP1196411A1 Bradykinin b1 receptor antagonists |
| 04/17/2002 | EP1196405A1 A comonomer, and a polymer stabilized with it during polymerization |
| 04/17/2002 | EP1196162A1 Procyanidin oligomers for inhibiting matrix metalloproteinases and medicine having effective composition of same |
| 04/17/2002 | EP1196153A2 Process for the improvement of spermatozoa fertilization activity |
| 04/17/2002 | EP1005464B1 Photochromic naphthopyrans |
| 04/17/2002 | EP0956285B1 Novel genipin derivative having anti hepatitis b virus activity |
| 04/17/2002 | EP0925293A4 Method of producing an extruded nutritional supplement product |
| 04/16/2002 | US6372921 Process for producing isochromanones and intermediates thereof |
| 04/16/2002 | US6372907 Labelled rhodamine dye-polypeptide conjugate, or salt thereof, comprising rhodamine-type parent xanthene ring substituted at xanthene c-9 carbon with substituted phenyl ring |
| 04/16/2002 | US6372776 Crystalline(−)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate |
| 04/16/2002 | US6372762 Heterocyclic compounds for nervous system disorders |
| 04/16/2002 | US6372739 Coumarone derivatives for drugs |
| 04/16/2002 | CA2260413C Terpenoid lactone compounds and their production process |
| 04/16/2002 | CA2009690C Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom |
| 04/11/2002 | WO2002028851A1 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | WO2001092249A3 Chiral and achiral synthesis of 2-acyl substituted chromanes and their derivatives |
| 04/11/2002 | US20020042527 Methods for separating a tocopherol from a tocopherol-containing mixture |
| 04/11/2002 | US20020042526 Processesand intermediatesfor preparing substitutedchromanol derivatives |
| 04/11/2002 | US20020042511 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/11/2002 | US20020041888 Suspension containing microspheres; apoptosis inducing compound |
| 04/11/2002 | CA2424993A1 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
| 04/10/2002 | EP1194424A1 Photochromic pyran derivatives |
| 04/10/2002 | EP1109802B1 Spirofluorenopyrans |
| 04/10/2002 | EP0954520B1 Isoflavone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 04/10/2002 | EP0948478B1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 04/10/2002 | EP0755928B1 5-aminoflavone derivatives |
| 04/10/2002 | EP0732329B1 Chroman derivative |
| 04/10/2002 | CN1343667A Prodn. method of benzodihydropyran carboxylic acid compound |
| 04/09/2002 | US6369242 Condensation of trimethylhydroquinone with isophytol or phytol in organic solvent with acid catalyst; bronsted acid co-catalyst; vitamin e manufacture |
| 04/09/2002 | US6369099 Method of locking 1 α-OH of vitamin D compounds in axial orientation |
| 04/09/2002 | CA2171675C Aromatic heterocyclic compounds; pharmaceutical and cosmetic compositions containing the same and their uses |
| 04/04/2002 | WO2002026729A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/04/2002 | WO2002026728A2 Antiviral methods and compounds |
| 04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | WO2001087871A3 Methods for producing amino substituted chromanes and intermediates therefor |
| 04/04/2002 | US20020040052 By administering a poyalkoxyflavonoid having a specific structure, especially nobiletin or tangeretin; plant extract from citrus family |
| 04/04/2002 | US20020040051 Solid dispersion of ipriflavone for oral administration and its manufacturing methods |
| 04/04/2002 | US20020040050 Immunosuppressive agents |
| 04/04/2002 | US20020039795 Method of preparing delta-9-tetrahydrocannabinol |
| 04/04/2002 | DE10044091A1 Chromanonderivate Chromanone |
| 04/04/2002 | CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | CA2423141A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/03/2002 | EP1192945A2 Use of an estrogen agonist/antagonist for treating osteoarthritis |
| 04/03/2002 | EP1192465A1 Detection using dendrimers bearing labels and probes |
| 04/03/2002 | EP1192146A1 Chroman derivatives resisting neurological disorders |
| 04/03/2002 | EP1192145A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| 04/03/2002 | EP1053472A4 Energy transfer dyes |
| 04/03/2002 | EP0937055B1 PROCESS FOR MANUFACTURING d,1-ALPHA-TOCOPHEROL |
| 04/03/2002 | EP0920645B1 Naphthopyrans, compositions and articles containing them |
| 04/03/2002 | EP0862646B1 Production of optically active 2-substituted tetrahydropyran-4-ones |
| 04/03/2002 | EP0825859B1 Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction |
| 04/03/2002 | EP0792468B1 Novel photochromic indeno-fused naphthopyrans |
| 04/03/2002 | EP0723536B1 An aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing |
| 04/03/2002 | CN1343208A Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 04/03/2002 | CN1082061C Cumarim and quinolinone derivatives for preparing liquid crystal orientation layers |
| 04/02/2002 | US6365758 Esterification by an acyclic carboxy acid in a hydrocarbon (b.p 80-200 degree c) or in a hydrocarbon mixture with an acyclic carbonate or gamma-lactone; azeotropic distillation of water |
| 04/02/2002 | US6365757 Culturing tissues of taxus wallichiania; isolation by partitioning the culture product residue, obtained by polar solvent extraction; desolventizing between water and chlorinated solvents; evaporation; chromotography; adsorption; |
| 04/02/2002 | US6365416 Method of preparing delta-9-tetrahydrocannabinol |
| 04/02/2002 | US6365301 Delocalized nitrogen, oxygen, sulfur or phoshorous onium cation; bis-fluorosulfonimidide anion or bis-difluorophos-phonylamidide anion |
| 04/02/2002 | US6365068 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
| 04/02/2002 | CA2039909C Substituted 3-thia- and 3-oxa-alkylflavones, a process for their preparation, the use thereof, medicaments based on these compounds and intermediates |
| 03/28/2002 | WO2002025648A1 Optical data carrier containing a phthalocyanine colouring agent as a light absorbing compound in the information layer |
| 03/28/2002 | WO2002025205A1 Optical data storage device containing a co-phthalocyanin complex in the optically writable information layer |
| 03/28/2002 | WO2002024689A1 Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis |
| 03/28/2002 | WO2002024678A1 Hovenodulinol, an active compound extracted from hovenia dulcis thunb, a process for preparing the same, and an alcohol decomposing agent or an agent for allevating lingering intoxication containing the same |
| 03/28/2002 | WO2002024677A1 N-disubstituted carbamoyloxy flavones |
| 03/28/2002 | WO2002024676A1 N-disubstituted carbamoyloxy flavones |
| 03/28/2002 | WO2001072735A3 Benzopyranes useful as tnf alpha inhibitors |
| 03/28/2002 | DE10043094A1 Verfahren zur Herstellung von Dihydrocumarin durch Hydrierung von Cumarin Process for the preparation of dihydrocoumarin by hydrogenation of coumarin |
| 03/27/2002 | EP1189897A1 Isoflavone metabolites |
| 03/27/2002 | EP1189896A1 Substituted 5-oxo-5,6,7,8-tetrahydro-4h-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of ampa |
| 03/27/2002 | EP1189628A1 Combination of tumor necrosis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
| 03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
| 03/27/2002 | EP1124817A4 Method of preparing delta-9-tetrahydrocannabinol esters |
| 03/27/2002 | EP1037885B1 Novel water soluble photochromic compounds |
| 03/27/2002 | EP0801564B1 Use of nebivolol as an anti-atherogenic |
| 03/27/2002 | CN1342137A N2 phenylamidine derivatives |
| 03/27/2002 | CN1081634C Process for chroman carboxylates |
| 03/26/2002 | US6362231 Calcium receptor active compounds |
| 03/26/2002 | US6362230 Alzheimer's disease |
| 03/26/2002 | US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use |
| 03/26/2002 | CA2095848C Process for the preparation of pyrimidine compounds |
| 03/21/2002 | WO2002022594A1 H-annellated benzo[f]chromenes |
| 03/21/2002 | WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors |
| 03/21/2002 | WO2002022556A1 Novel amide derivatives and medicinal use thereof ugs |
| 03/21/2002 | WO2001078529A3 Compositions and methods for improving vascular health |
| 03/21/2002 | WO2001034135A3 Oncolytic combinations for the treatment of cancer |
| 03/21/2002 | US20020035276 Method for producing chroman-carboxylic acid |
| 03/21/2002 | US20020035264 Therapy for vision disorders |
| 03/21/2002 | US20020035144 Solubility, bioavailability; antiinflammatory agents |
| 03/21/2002 | US20020035114 Substituted dimeric compounds |
| 03/21/2002 | US20020034797 Modified modular pks with retained scaffold |
| 03/21/2002 | US20020034761 Methods of labelling polynucleotides with dibenzorhodamine dyes |